Cited by 102Sphingolipid Metabolism and SignalingMetabolomics and Mass Spectrometry StudiesLipid metabolism and biosynthesis

A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans

Open access
Blachnio‐Zabielska, Agnieszka U., Persson, Xuan‐Mai T., Koutsari, Christina, Zabielski, Piotr, Jensen, Michael D.·2012·Rapid Communications in Mass Spectrometry

Abstract

RATIONALE: Sphingolipids are important components of cell membranes that serve as cell signaling molecules; ceramide plays a central role in sphingolipid metabolism. De novo ceramide biosynthesis depends on fatty acid availability, but whether muscle uses circulating free fatty acids or pre‐existing intracellular stores is unknown. Our goal was to develop a method to detect the incorporation of intravenously infused [U‐ 13 C]palmitate into intramyocellular ceramides. METHODS: We used liquid chromatography/tandem mass spectrometry (LC/MS/MS) to measure the concentrations of different sphingolipid species and 13 C‐isotopic enrichment of 16:0‐ceramide. Chromatographic separation was performed using ultra‐performance liquid chromatography. The analysis was performed on a triple quadrupole mass spectrometer using a positive ion electrospray ionization source with selected reaction monitoring (SRM). RESULTS: The sphingolipids ions, except enriched ceramide, were monitored as [M+2+H] + . The [ 13 C 16 ]16:0‐ceramide was monitored as [M+16+H] + . By monitoring two different transitions of the [ 13 C 16 ]16:0‐ceramide (554/536 and 554/264) we could indirectly measure enrichment of the palmitate that is not a part of the sphingoid base. Concentration and enrichment could be measured using 20 mg of muscle obtained from volunteers receiving a low dose [U‐ 13 C]palmitate infusion. CONCLUSIONS: LC/MS/MS can be used to detect the incorporation of plasma palmitate into muscle ceramides in humans, in vivo . Copyright © 2012 John Wiley & Sons, Ltd.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/rcm.6216

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Different approaches for the measurement of ceramide synthesis in vivo have been proposed, e.g. infusion of U13C palmitate as ceramide precursors in humans to measure de novo synthesis in skeletal muscle or labelled palmitate to measure hepatic ceramide kinetics in rat models.

    “Different approaches for the measurement of ceramide synthesis in vivo have been proposed, e.g. the infusion of U13C palmitate as ceramide precursors, used in humans to measure de novo synthesis of ceramides in skeletal muscle[119], [120], [121] or labelled palmitate used to measure hepatic ceramide kinetics in rat models.122,123”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Blachnio‐Zabielska, A. U., Persson, X. T., Koutsari, C., Zabielski, P., & Jensen, M. D.
Affiliations
  • Endocrine Research Unit Mayo Clinic Rochester MN 55905 USA
  • Mayo Clinic (US)
Venue
Rapid Communications in Mass Spectrometry
Publisher
Wiley
Published
2012-03-22
Volume
26
Issue
9
Pages
1134-1140
ISSN
  • 0951-4198 (ISSN-L)
  • 1097-0231
OpenAlex
W1608393181
Cited by
102
References
24
Citations by year
2026: 2 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 11 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 3
FWCI
2.83
Type
journal article
Language
en
Open access
Locations
  • Rapid Communications in Mass Spectrometry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (UL1TR000135)
  • U.S. Public Health Service
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 40484, P30DK050456, DK 45343, DK50456, R37DK040484, R01DK045343, R01DK040484)
  • National Center for Research Resources (RR-00585, M01RR000585, UL1RR024150)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
ceramide, sphingolipid metabolism, palmitate incorporation, isotope enrichment, muscle, plasma free fatty acids, ceramide biosynthesis
MeSH terms
Carbon Isotopes, Ceramides, Chromatography, High Pressure Liquid, Humans, Palmitates, Linear Models, Muscle, Skeletal, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review